(EAF) GrafTech International - Overview
Stock: Graphite Electrodes, Petroleum Needle Coke
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 339% |
| Relative Tail Risk | -9.05% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.10 |
| Alpha | -68.92 |
| Character TTM | |
|---|---|
| Beta | 1.926 |
| Beta Downside | 2.606 |
| Drawdowns 3y | |
|---|---|
| Max DD | 90.53% |
| CAGR/Max DD | -0.51 |
Description: EAF GrafTech International January 01, 2026
GrafTech International Ltd. (NYSE:EAF) designs, manufactures, and sells graphite and carbon-based products globally, most notably graphite electrodes for electric-arc furnace (EAF) steelmaking and petroleum-derived needle coke used in electrode and synthetic graphite production. The firm reaches customers via a direct sales force, independent representatives, and distributors, and traces its roots back to 1886 with headquarters in Brooklyn Heights, Ohio.
Key operating metrics that investors watch include: (1) 2023 revenue of roughly $1.2 billion, with a gross margin of ~27%, reflecting the high-value nature of its specialty carbon products; (2) a 2024-25 forward-looking EBITDA margin of 15-18% as the company benefits from rising EAF steel capacity in China and the United States; and (3) exposure to commodity price risk, where petroleum needle-coke prices have risen >30% YoY due to tighter refining margins and increased demand from the battery-grade graphite market. The primary economic drivers are global steel production trends (especially the shift from blast-furnace to electric-arc processes), the growth of renewable-energy-related metal demand (copper, nickel), and the price dynamics of feedstock coke.
For a data-driven deep-dive into GrafTech’s valuation assumptions and scenario analysis, consider exploring the analyst tools on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 0.5
| Net Income: -204.2m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.11 > 0.02 and ΔFCF/TA -8.10 > 1.0 |
| NWC/Revenue: 83.32% < 20% (prev 75.83%; Δ 7.48% < -1%) |
| CFO/TA -0.08 > 3% & CFO -87.1m > Net Income -204.2m |
| Current Ratio: 4.22 > 1.5 & < 3 |
| Outstanding Shares: last quarter (259.0m) vs 12m ago 0.49% < -2% |
| Gross Margin: -0.39% > 18% (prev -0.10%; Δ -29.13% > 0.5%) |
| Asset Turnover: 46.37% > 50% (prev 47.39%; Δ -1.02% > 0%) |
| Interest Coverage Ratio: -0.47 > 6 (EBITDA TTM 7.22m / Interest Expense TTM 117.4m) |
Altman Z'' -1.31
| A: 0.39 (Total Current Assets 569.8m - Total Current Liabilities 135.0m) / Total Assets 1.11b |
| B: -0.86 (Retained Earnings -947.8m / Total Assets 1.11b) |
| C: -0.05 (EBIT TTM -54.7m / Avg Total Assets 1.13b) |
| D: -0.73 (Book Value of Equity -952.6m / Total Liabilities 1.30b) |
| Altman-Z'' Score: -1.31 = CCC |
Beneish M -4.00
| DSRI: 1.02 (Receivables 88.3m/89.5m, Revenue 521.9m/541.7m) |
| GMI: 1.00 (fallback, negative margins) |
| AQI: -5.03 (AQ_t -0.39 / AQ_t-1 0.08) |
| SGI: 0.96 (Revenue 521.9m / 541.7m) |
| TATA: -0.11 (NI -204.2m - CFO -87.1m) / TA 1.11b) |
| Beneish M-Score: -6.72 (Cap -4..+1) = AAA |
What is the price of EAF shares?
Over the past week, the price has changed by -44.14%, over one month by -52.15%, over three months by -29.84% and over the past year by -43.36%.
Is EAF a buy, sell or hold?
- StrongBuy: 0
- Buy: 0
- Hold: 5
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the EAF price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 14.8 | 74.8% |
| Analysts Target Price | 14.8 | 74.8% |
| ValueRay Target Price | 5.1 | -40% |
EAF Fundamental Data Overview February 03, 2026
P/S = 0.7475
P/B = 13.8553
Revenue TTM = 521.9m USD
EBIT TTM = -54.7m USD
EBITDA TTM = 7.22m USD
Long Term Debt = 1.09b USD (from longTermDebt, last quarter)
Short Term Debt = 2.05m USD (from shortTermDebt, last fiscal year)
Debt = 1.14b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 962.6m USD (from netDebt column, last quarter)
Enterprise Value = 1.35b USD (390.1m + Debt 1.14b - CCE 177.6m)
Interest Coverage Ratio = -0.47 (Ebit TTM -54.7m / Interest Expense TTM 117.4m)
EV/FCF = -11.23x (Enterprise Value 1.35b / FCF TTM -120.4m)
FCF Yield = -8.90% (FCF TTM -120.4m / Enterprise Value 1.35b)
FCF Margin = -23.08% (FCF TTM -120.4m / Revenue TTM 521.9m)
Net Margin = -39.13% (Net Income TTM -204.2m / Revenue TTM 521.9m)
Gross Margin = -0.39% ((Revenue TTM 521.9m - Cost of Revenue TTM 523.9m) / Revenue TTM)
Gross Margin QoQ = 7.16% (prev -0.10%)
Tobins Q-Ratio = 1.22 (Enterprise Value 1.35b / Total Assets 1.11b)
Interest Expense / Debt = 2.15% (Interest Expense 24.5m / Debt 1.14b)
Taxrate = 21.0% (US default 21%)
NOPAT = -43.2m (EBIT -54.7m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 4.22 (Total Current Assets 569.8m / Total Current Liabilities 135.0m)
Debt / Equity = -5.87 (negative equity) (Debt 1.14b / totalStockholderEquity, last quarter -194.4m)
Debt / EBITDA = 133.4 (Net Debt 962.6m / EBITDA 7.22m)
Debt / FCF = -7.99 (negative FCF - burning cash) (Net Debt 962.6m / FCF TTM -120.4m)
Total Stockholder Equity = -136.8m (last 4 quarters mean from totalStockholderEquity)
RoA = -18.14% (Net Income -204.2m / Total Assets 1.11b)
RoE = 149.3% (negative equity) (Net Income TTM -204.2m / Total Stockholder Equity -136.8m)
RoCE = -5.73% (EBIT -54.7m / Capital Employed (Equity -136.8m + L.T.Debt 1.09b))
RoIC = -4.54% (negative operating profit) (NOPAT -43.2m / Invested Capital 953.1m)
WACC = 4.58% (E(390.1m)/V(1.53b) * Re(13.01%) + D(1.14b)/V(1.53b) * Rd(2.15%) * (1-Tc(0.21)))
Discount Rate = 13.01% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 0.34%
Fair Price DCF = unknown (Cash Flow -120.4m)
EPS Correlation: -92.70 | EPS CAGR: -28.43% | SUE: 0.87 | # QB: 1
Revenue Correlation: -87.23 | Revenue CAGR: -21.87% | SUE: 0.43 | # QB: 0
EPS next Quarter (2026-03-31): EPS=-1.00 | Chg30d=+0.000 | Revisions Net=-1 | Analysts=2
EPS next Year (2026-12-31): EPS=-3.26 | Chg30d=+0.000 | Revisions Net=-1 | Growth EPS=+34.0% | Growth Revenue=+11.1%